Thursday, December 26, 2024
12/26/2024
ABSTRACT: Idiopathic pulmonary fibrosis (IPF) is an age-associated disease characterized by progressive accumulation of scar tissue in the lungs. High morbidity rates in patients with IPF mandate more effective treatments. A new paradigm implicates accumulation of alveolar epithelial cells (AECs) that are compromised by loss of endoplasmic reticulum (ER) chaperone glucose-regulated protein 78 (GRP78), a master regulator of proteostasis, in the pathogenesis of lung fibrosis. However, the molecular mechanisms and metabolic landscapes characteristic of age-related PF have not been identified. Our goal in this project is to use alveolar epithelial type II (AT2) cell-specific Grp78-KO mice, modeling the age-specific GRP78 reductions seen in AECs, to establish how GRP78-loss impairs mitochondrial bioenergetics and biosynthesis, leading to development of an aging phenotype in AT2 cells and subsequent lung fibrosis. Perturbed proteostasis and activation of ER stress response signaling known as the unfolded protein response (UPRER) have been suggested as one possible mechanism underlying observed AEC abnormalities. We found that GRP78 is downregulated accompanied by activation of ER stress/UPRER in AT2 cells from IPF patients and aged mice/human individuals. We further show that GRP78 undergoes reactive oxygen species (ROS)-induced carbonylation (the most common form of oxidative stress-induced damage to proteins) in AT2 cells from IPF patients and aged mice. In our model, AT2 cell-specific Grp78-KO mice develop aging-associated phenotypes including disrupted proteostasis, mitochondrial dysfunction, abnormal mTOR signaling and metabolism, apoptosis and senescence in AT2 cells with subsequent lung fibrosis. In this study, we highlight an emerging theme that GRP78 loss-disrupted proteostasis leads to gradual decline of mitochondrial function and metabolic fitness, which in turn is tightly linked with phenotypic changes of AECs (apoptosis and senescence) with the endpoint of lung fibrosis. The use of Grp78-KO mice to model GRP78 loss in AECs allows us to rigorously examine how impaired proteostasis promotes development of an aging phenotype in AT2 cells. Guided by our published and unpublished results, we hypothesize that age-related AEC-specific downregulation of GRP78 induces unresolved ER stress/UPRER, which in turn dysregulates metabolism and overactivates mTOR leading to AEC dysfunction and subsequent lung fibrosis in IPF. We propose the following specific aims to address this hypothesis: AIM 1: To identify mechanisms whereby disturbed GRP78-dependent mitochondrial function and metabolism in AEC promote the development of PF. Aim 2: To characterize the role and mechanisms of GRP78 reduction in mediating AEC aging phenotype and PF. Aim 3: To determine the therapeutic potential of targeting GRP78 loss-mediated pathways in age-associated PF in vivo and in vitro. The proposed studies will provide rationale for how therapeutics that target metabolism might achieve specificity for pro-fibrotic cells as anti-IPF agents.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).